Vincerx Pharma VINC

Quarterly report 2025-Q1
added 05-15-2025

Country	USA
IPO year	2020
Industry	-
Stock Exchange	NASDAQ CAPITAL

Shares	21.3 K
Market Cap^[1]	$ 13 K
EBITDA (LTM)	$ -59.3 M
P/E (LTM)	-
P/S (LTM)	-
EPS (LTM)	-13.08

References

Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.